Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a NSCLC patient treated with afatinib

J Dtsch Dermatol Ges. 2018 Feb;16(2):199-201. doi: 10.1111/ddg.13412. Epub 2018 Jan 12.

Authors

Viktoria P Nühnen¹, Michael P Schön¹, Rotraut Mössner¹

Affiliation

¹ Department of Dermatology, Venereology, and Allergology, University Medical Center, Göttingen, Germany.

PMID: 29328518
DOI: 10.1111/ddg.13412

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma / drug therapy*
Adenocarcinoma / pathology
Afatinib / adverse effects*
Afatinib / therapeutic use
Aftercare
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Biopsy
Female
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Prednisolone / therapeutic use
Skin / drug effects
Skin / pathology
Stevens-Johnson Syndrome / diagnosis*
Stevens-Johnson Syndrome / drug therapy
Stevens-Johnson Syndrome / etiology*
Stevens-Johnson Syndrome / pathology

Substances

Antineoplastic Agents
Afatinib
Prednisolone